Service · 03
Reimbursement & Commercial Due Diligence
Investor-grade diligence for venture capital, private equity, and investment banking teams evaluating healthcare targets — assessing coding and coverage risk, payer dynamics, pricing durability, and the realistic path to reimbursement.
Who this is for
- VC and growth-equity investors evaluating healthcare assets.
- Private equity sponsors and portfolio operators.
- Investment banks supporting sell-side and buy-side processes.
What we deliver
- Reimbursement risk assessment across coding, coverage, and payment.
- Payer dynamics, pricing durability, and policy-trend analysis.
- Commercial path validation against the investment thesis.
- Concise, decision-grade memos delivered on transaction timelines.
How we work
01
Scope
Align on the investment thesis and the questions diligence must answer.
02
Analyze
Pressure-test coding, coverage, and payer economics against reality.
03
Synthesize
Deliver clear findings, risks, and management questions.
04
Support
Stay engaged through IC, close, and post-close value creation.
Ready to talk?
Let's discuss your reimbursement and access strategy.
Senior, partner-led engagements. Confidential by default.